Pioglitazone and bladder cancer: A propensity score matched cohort study
British Journal of Clinical Pharmacology, 06/01/2012
Clinical Article
Li W et al. – The results suggest that pioglitazone may not be significantly associated with an increased risk of bladder cancer in patients with type 2 diabetes.



